Prentiss Smith & Co’s Core Laboratories CLB Stock Holding History

Prentiss Smith & Co’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,000	Closed	-$120K	–	245
2016 Q4	$120K	Hold	1,000	–	–	0.07%	74
2016 Q3	$112K	Hold	1,000	–	–	0.06%	89
2016 Q2	$124K	Hold	1,000	–	–	0.07%	85
2016 Q1	$112K	Hold	1,000	–	–	0.06%	90
2015 Q4	$109K	Hold	1,000	–	–	0.06%	91
2015 Q3	$100K	Hold	1,000	–	–	0.06%	92
2015 Q2	$114K	Hold	1,000	–	–	0.06%	88
2015 Q1	$104K	Hold	1,000	–	–	0.05%	95
2014 Q4	$120K	Buy	+1,000	New	+$131K	0.06%	89

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Prentiss Smith & Co's CLB Position: Q1 2017 in Review

Prentiss Smith & Co sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 1,000 shares — an estimated $120K sold.

Prentiss Smith & Co first reported a position in CLB in Q4 2014 and held it in 9 quarters. The position peaked at $124K in Q2 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

Prentiss Smith & Co reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
Prentiss Smith & Co sold 1,000 Core Laboratories shares in Q1 2017, an estimated $120K.
Prentiss Smith & Co first reported a position in Core Laboratories in Q4 2014 and held it in 9 quarters.
Prentiss Smith & Co's Core Laboratories position peaked at $124K in Q2 2016.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Prentiss Smith & Co's 13F filing for Q1 2017, filed 13 Apr 2017.